| Date |
Title |
|
|
02/19/20
|
Alkermes to Present at the 9th Annual SVB Leerink Global Healthcare Conference
|
|
|
02/13/20
|
Alkermes Plc Reports Financial Results for the Fourth Quarter and Year Ended Dec. 31, 2019 and Provides Financial Expectations for 2020
|
|
|
02/06/20
|
Alkermes to Host Conference Call to Discuss Fourth Quarter and Year-End 2019 Financial Results
|
|
|
01/28/20
|
Alkermes Announces U.S. Food and Drug Administration Acceptance of ALKS 3831 New Drug Application for Treatment of Schizophrenia and Bipolar I Disorder
|
|
|
01/08/20
|
Alkermes' Corporate Presentation to be Webcast at the 38th Annual J.P. Morgan Healthcare Conference
|
|
